CHU de Saint-Etienne
Saint-Etienne, 42000, France
NCT Number: NCT00725166
To reach the goals of living longer in better medical conditions, many countries reach the same conclusion: new strategies have to be developed to avoid, or at least limit, the effects of age; this requires a better knowledge of the mechanisms of aging. Our project focuses on the loss of muscle mass associated with aging, called sarcopenia. Sarcopenia unavoidably leads to impaired mobility and poor balance, which contributes to loss of functional autonomy and to increased prevalence for severe falls. Skeletal muscle also plays a central role as a reserve for energy and amino acids. Hence, sarcopenia further triggers severe side metabolic effects such as frailty among elderly persons. The precise mechanisms of muscle aging are still mostly unknown, although many theories have been proposed.
The present study aims at better understanding the mechanisms of skeletal muscle loss associated with aging. Using muscle biopsies from young and old subjects, the differential expression profiles of mRNA will be obtained through chips that will evaluate more than 39000 transcripts. On the same samples, proteomic analyses will involve two complementary approaches: (1) bidimensional electrophoresis (2DGE) coupled to mass spectrometry (MALDI-ToF) for dominant proteins; (2) Western-blot (more than 800 antibodies) targeting regulating proteins not detectable using 2DGE. Complementary histological studies (immunohisto-fluorescence, confocal microscopy) will specify the localisation of the major biomarkers in the muscle biopsies.
The results of that research will have applications in the medium term and will lead to nutritional interventions to modulate specific metabolic pathways and improve the quality of life in the elderly.
Looking for future studies?
Notify Me19 year–76 year
Male
Observational
Saint-Etienne, 42000, France
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
W1 - Blood test
W2 - Maximal metabolic test using a cycloergometer
W3 - Muscular biopsy
Time frame: During biopsie (W3)
Time frame: During biopsie (W3)
Time frame: during biopsie (W3)
Time frame: during biopsie (W3)
Centre Hospitalier Universitaire de Saint Etienne
Other
Acronym: CERA
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03344718
Atrophy, Avitaminosis
Tainan, Taiwan
View Trial DetailsNCT07065448
Atrophy, Elderly
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT04777279
Atrophy, Behavior
Taipei, Taiwan
View Trial DetailsNCT03000907
Atrophy, Behavior
Mataró, Barcelona, Spain
View Trial Details